South Dakota 2024 Regular Session

South Dakota House Bill HB1125

Introduced
1/22/24  
Refer
1/22/24  
Report Pass
1/30/24  
Engrossed
1/31/24  
Refer
2/1/24  
Report Pass
2/21/24  
Enrolled
2/26/24  

Caption

Prohibit the chemical modification or conversion of industrial hemp and the sale or distribution of chemically modified or converted industrial hemp and to provide a penalty therefor.

Impact

The enactment of HB 1125 will have significant implications for the agricultural sector, particularly for farmers and businesses involved in the processing and sale of hemp products. By restricting chemical modifications, the bill aligns with trends toward more natural agricultural products and may enhance consumer trust in hemp-derived goods. However, it may also limit innovation within the industry, particularly regarding the production of various cannabinoid products that are chemically modified for different uses. Producers will need to adapt to these regulatory requirements while finding ways to meet market demands.

Summary

House Bill 1125 seeks to prohibit the chemical modification or conversion of industrial hemp, as well as the sale and distribution of chemically modified or converted hemp products in South Dakota. The bill defines key terms related to hemp, including what constitutes industrial hemp and chemically derived cannabinoids. Additionally, it establishes penalties for violations, categorizing them as Class 2 misdemeanors. The aim of the bill is to ensure that products derived from hemp maintain their natural integrity and do not undergo chemical alterations that could affect their classification or safety.

Sentiment

The sentiment surrounding HB 1125 appears to be largely supportive among legislators focused on agricultural integrity and health safety. Proponents argue that the bill will protect consumers from potentially harmful products and preserve the natural qualities of hemp. Conversely, some industry stakeholders express concerns that the restrictions could hinder growth and limit options for consumers seeking diverse cannabinoid products, which could affect their market competitiveness. This division highlights the tension between health regulations and innovation in the hemp industry.

Contention

Notable points of contention include the definition of chemically modified cannabinoids and the allowable limits for various forms of hemp-derived products. Critics of the bill may argue that it prevents the legal production of popular products like delta-8 THC, which has gained substantial traction in recent years. Supporters, however, emphasize the necessity of maintaining safety and purity within the industry. This aspect of the debate will likely continue as stakeholders assess the balance between regulation and market freedom in this evolving agricultural sector.

Companion Bills

No companion bills found.

Similar Bills

CA AB420

Cannabis: industrial hemp.

CA AB228

Food, beverage, and cosmetic adulterants: industrial hemp products.

CO SB205

Intoxicating Hemp And Tetrahydrocannabinol Products

CA AB2223

Cannabis: industrial hemp.

LA SB219

Provides relative to industrial hemp. (gov sig) (EG1 INCREASE GF EX See Note)

NJ A5440

Prohibits production and sale of products containing delta-8 tetrahydrocannabinol.

VA HB2775

Hemp product; clarifies definition.

NJ S3944

Prohibits production and sale of products containing delta-8 tetrahydrocannabinol.